Skin Pathology Assessment With Optical Technologies
NCT04295824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-05-06
Summary
The Skin Pathology assessment with Optical Technologies (SPOT) study aims to assess the feasibility of recently developed light-based skin imaging tools such as Optical Coherence Tomography (OCT) for the study of eczema (dermatitis \[AD\]).
Tools such as OCT have enabled us to see beneath the skin surface, allowing us to see changes in our skin which are hidden and impossible to assess by eye, simply by shining harmless light into the skin. The investigators want to understand what these changes represent in the broader context of eczema.
To do this, the investigators would like to recruit 60 volunteers who have a range of different eczema severities. The investigators would also like to recruit 20 healthy volunteers, who have never suffered from eczema. All volunteers would be aged between 11 and 60.
The study is based at the Royal Hallamshire Hospital in Sheffield, with consent and sample-collection taking place at either the hospital's Clinical Research Facility or the Sheffield Children's Hospital. The study consists of a single main visit, which is expected to take approximately 3 hours, and a short follow up visit 2-4 weeks later.
During the main study visit, the investigators will collect a range of measurements from the inner elbows and cheeks using harmless topical probes (Including OCT). These measurements include information about the skin's layers, blood flow, composition, water loss, acidity and redness. The investigators will also collect some samples, including tape-strips, a saliva sample and blood samples. For adult participants the investigators will also collect 2-4 skin biopsies from the inner elbows, which involves removing small pieces of skin under a local anaesthetic.
It is our hope that by demonstrating the advantages of new harmless imaging techniques, the investigators can reduce the need for invasive procedures in the future. Long term, this may help us to improve the way healthcare professionals monitor and treat eczema.
Conditions
- Atopic Dermatitis Eczema
Interventions
- DIAGNOSTIC_TEST
-
Skin imaging and Skin biopsy
Imaging includes: * Structural Optical Coherence Tomography (OCT) - Skin thickness/roughness. * Angiographic OCT- Vessel depth/morphology. * Polarisation-sensitive OCT - Tissue birefringence / collagen index. * Skin biopsies will be taken from the same volar forearm site as the imaging is performed.
Sponsors & Collaborators
-
University of Sheffield
collaborator OTHER -
Sheffield Children's NHS Foundation Trust
collaborator OTHER -
Sheffield Teaching Hospitals NHS Foundation Trust
lead OTHER
Principal Investigators
-
Michael J Cork, MD+PhD · University of Sheffield & Sheffield Teaching Hospitals
-
Simon G Danby, PhD · University of Sheffield
Eligibility
- Min Age
- 11 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-06
- Primary Completion
- 2022-07-29
- Completion
- 2022-07-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age
NCT03684343 ·Status: TERMINATED ·Phase: NA
-
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool
NCT06351449 ·Status: NOT_YET_RECRUITING
-
Diagnostic Accuracy of Teledermatology in Patch Test Interpretation
NCT06213545 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of Chronic Hand Eczema
NCT05026554 ·Status: RECRUITING
-
Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
NCT02493816 ·Status: COMPLETED ·Phase: PHASE1
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
Monitoring Of Scratch Via Accelerometry In Children
NCT03873220 ·Status: COMPLETED
-
A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners
NCT05763914 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980 ·Status: COMPLETED
-
Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis
NCT01545284 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hand Eczema in the Health Care Sector
NCT04449575 ·Status: UNKNOWN
-
Assessment of Chilbains Occuring During Covid-19 Infection
NCT04344119 ·Status: UNKNOWN
-
Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel
NCT06237010 ·Status: COMPLETED
-
A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema
NCT01899287 ·Status: COMPLETED ·Phase: NA
-
A Study of KHK4827 in Subjects With Palmoplantar Pustulosis
NCT04061252 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.
NCT04888234 ·Status: UNKNOWN ·Phase: PHASE2
-
Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis
NCT02844452 ·Status: COMPLETED ·Phase: NA
-
A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)
NCT04262791 ·Status: TERMINATED ·Phase: PHASE1
-
A National Registry For Patients With Hidradenitis Suppurativa
NCT03289585 ·Status: COMPLETED
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2